Crisis Investing: Nick Giambruno’s Next Investment Megatrens
403% in just over eight months.That’s how much one tiny psychedelic medicine stock is up since Nick Giambruno recommended it to readers of the Crisis Investing advisory.
The #1 stock of 2022? [name and ticker]
403% in just over eight months.That’s how much one tiny psychedelic medicine stock is up since Nick Giambruno recommended it to readers of the Crisis Investing advisory.
Casey Research’s Nick Giambruno shares new Crisis Investing Newsletter report called #1 “Lateral IPO” of 2021. It’s about a company that has officially stated their plan to list on the Nasdaq. And Nick Giambruno can show you how to get access to their shares BEFORE their “Lateral IPO”.
Casey Research’s Nick Giambruno shares new Crisis Investing newsletter report called The “Holy Serum” Millionaire Playbook. It’s about “Holy Serum” radical discovery and how this could launch $5 stock on a 4,100% run.
The new Crisis Investing Advisory report features Nick Giambruno’s Tiny Defense Supplier where Doug Casey’s right hand shares an urgent message to every American investor about a tiny company that will potentially be the next big defense supplier for the US.
Editor’s note: Crisis Investing chief analyst Nick Giambruno believes everyone should hold two specific assets to hedge against impending crises and volatility… And with Casey Research founder Doug Casey’s most recent predictionsabout the uncertain future of America… the economy… and the world, it’s more important than ever to prepare yourself for what’s ahead… When two federal agents showed … Read more